Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | -30K | 8K | 108K | -117K |
| Cost of revenue | 0 | 42K | 1K | 23K |
| Gross profit | -30K | -34K | 107K | -140K |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 0 | 1K | — |
| Other operating expenses | 108K | -2.2M | 715K | -1.7M |
| Operating income | 315K | 2.1M | -611K | 1.6M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 0 | 1K | 0 | 0 |
| Other income expense | — | — | — | — |
| Pretax income | 315K | 1.4M | -611K | -25K |
| Tax provision | 0 | 0 | 0 | 0 |
| Net income | 315K | 1.4M | -611K | -25K |
| Basic EPS | 0.0 | — | -0.1 | — |
| Diluted EPS | 0.0 | — | -0.1 | — |
| Basic average shares | 7.8M | — | 7.8M | — |
| Diluted average shares | 7.8M | — | 7.8M | — |
| EBITDA | 317K | 1.4M | -609K | -22K |
| Net income from continuing op. | 315K | 1.4M | -611K | 13K |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |